C-101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameC-101
Drug Alias NameMyodurcarnitine + leupeptin
ClassificationBiologics
Mechanisms of ActionCarnitine acetylase stimulantsCalpain1/2 inhibitors
TargetsCarnitine acetylaseCalpain1/2
Therapy Area/IndicationsMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Levocarnitine
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A